Biolitec Meditech India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 1 Year 9 Months
- Open Charges ₹ 16.00 Cr
About Biolitec Meditech India
Biolitec Meditech India Private Limited (BMIPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 29 April 2023 (One year and nine months 28 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹16.00 Cr.
Preeti Lodha and Sreetama Kar serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U26600KA2023FTC173016
- Company No.
173016
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
29 Apr 2023
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Who are the key members and board of directors at Biolitec Meditech India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Preeti Lodha  | Director | 29-Apr-2023 | Current |
| Sreetama Kar | Director | 29-Apr-2023 | Current |
Financial Performance of Biolitec Meditech India.
Enhance accessibility to Biolitec Meditech India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Biolitec Meditech India?
Unlock access to Biolitec Meditech India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Biolitec India Private LimitedPreeti Lodha and Sreetama Kar are mutual person
Advanced Clinical Research Private LimitedPreeti Lodha and Sreetama Kar are mutual person
Charges (Loans)
₹160.00 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 16.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Jul 2023 | Axis Bank Limited | ₹16.00 Cr | Open |
How Many Employees Work at Biolitec Meditech India?
Unlock and access historical data on people associated with Biolitec Meditech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biolitec Meditech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biolitec Meditech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.